Extracorporeal Membrane Oxygenation for Severe ARDS Due to Immune Diffuse Alveolar Hemorrhage: A Retrospective Observational Study

Chest. 2020 Mar;157(3):744-747. doi: 10.1016/j.chest.2019.10.021. Epub 2019 Nov 9.
No abstract available

Publication types

  • Letter
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anti-Glomerular Basement Membrane Disease / complications
  • Anti-Glomerular Basement Membrane Disease / drug therapy
  • Anti-Glomerular Basement Membrane Disease / immunology
  • Extracorporeal Membrane Oxygenation*
  • Female
  • Granulomatosis with Polyangiitis / complications
  • Granulomatosis with Polyangiitis / drug therapy
  • Granulomatosis with Polyangiitis / immunology
  • Hemorrhage / complications*
  • Hemorrhage / immunology
  • Hospital Mortality*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Intensive Care Units
  • Length of Stay / statistics & numerical data
  • Lung Diseases / complications*
  • Lung Diseases / immunology
  • Male
  • Microscopic Polyangiitis / complications
  • Microscopic Polyangiitis / drug therapy
  • Microscopic Polyangiitis / immunology
  • Middle Aged
  • Myositis / complications
  • Myositis / drug therapy
  • Myositis / immunology
  • Pulmonary Alveoli
  • Respiration, Artificial / statistics & numerical data
  • Respiratory Distress Syndrome / etiology
  • Respiratory Distress Syndrome / therapy*
  • Retrospective Studies
  • Vasculitis / complications
  • Vasculitis / drug therapy*
  • Vasculitis / immunology

Substances

  • Immunosuppressive Agents

Supplementary concepts

  • Antisynthetase syndrome